Prime Medicine Inc Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| ALPHABET INC. | 02/13/2026 | 16.56 M | $57.47 M | 0.00% | 10.32% |
| BLACKROCK, INC. | 02/12/2026 | 8.27 M | $28.69 M | 46.33% | 5.15% |
| VANGUARD GROUP INC | 01/29/2026 | 6.47 M | $22.44 M | 31.41% | 4.03% |
| T. ROWE PRICE INVESTMENT MANAGEMENT, INC. | 02/19/2026 | 6.00 M | $20.80 M | -34.96% | 3.74% |
| ARK INVESTMENT MANAGEMENT LLC | 02/11/2026 | 5.37 M | $18.63 M | -2.00% | 3.34% |
| STATE STREET CORP | 02/13/2026 | 5.10 M | $17.68 M | 292.98% | 3.17% |
| SUMITOMO MITSUI TRUST HOLDINGS, INC. | 01/23/2026 | 3.25 M | $11.26 M | -10.59% | 2.02% |
| NIKKO ASSET MANAGEMENT AMERICAS, INC. | 02/11/2026 | 3.25 M | $11.20 M | -10.59% | 2.02% |
| CASDIN CAPITAL, LLC | 02/17/2026 | 3.17 M | $10.99 M | 0.00% | 1.97% |
| BALYASNY ASSET MANAGEMENT L.P. | 02/17/2026 | 3.12 M | $10.84 M | 6,426.36% | 1.95% |
| WOODLINE PARTNERS LP | 02/17/2026 | 3.00 M | $10.42 M | 0.01% | 1.87% |
| GEODE CAPITAL MANAGEMENT, LLC | 02/09/2026 | 2.63 M | $9.12 M | 48.76% | 1.64% |
| UBS GROUP AG | 01/29/2026 | 2.44 M | $8.47 M | 700.79% | 1.52% |
| FMR LLC | 02/17/2026 | 2.18 M | $7.55 M | -22.62% | 1.36% |
| 02/17/2026 | 1.79 M | $6.22 M | 100.00% | 1.12% | |
| GOLDMAN SACHS GROUP INC | 03/25/2026 | 1.76 M | $6.09 M | 327.47% | 1.09% |
| TWO SIGMA INVESTMENTS, LP | 02/17/2026 | 1.63 M | $5.65 M | 263.96% | 1.02% |
| D. E. SHAW & CO., INC. | 02/17/2026 | 1.55 M | $5.38 M | -29.99% | 0.97% |
| FARALLON CAPITAL MANAGEMENT LLC | 02/17/2026 | 1.24 M | $4.31 M | -73.88% | 0.77% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 02/17/2026 | 1.18 M | $4.08 M | 101.35% | 0.73% |
| MORGAN STANLEY | 02/13/2026 | 1.17 M | $4.06 M | 60.04% | 0.73% |
| RENAISSANCE TECHNOLOGIES LLC | 02/12/2026 | 1.15 M | $3.99 M | 1.28% | 0.72% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 02/13/2026 | 936.82 K | $3.25 M | 63.45% | 0.58% |
| NORTHERN TRUST CORP | 02/17/2026 | 842.15 K | $2.92 M | 38.51% | 0.52% |
| GREENWICH WEALTH MANAGEMENT LLC | 02/10/2026 | 740.00 K | $2.57 M | 2.78% | 0.46% |
| HRT FINANCIAL LP | 02/12/2026 | 655.35 K | $2.27 M | 195.92% | 0.41% |
| BANK OF AMERICA CORP /DE/ | 02/17/2026 | 648.01 K | $2.25 M | 484.63% | 0.40% |
| POINT72 ASSET MANAGEMENT, L.P. | 02/17/2026 | 551.03 K | $1.91 M | 100.00% | 0.34% |
| MOORE CAPITAL MANAGEMENT, LP | 02/17/2026 | 500.00 K | $1.74 M | 0.00% | 0.31% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 02/17/2026 | 471.70 K | $1.64 M | 75.48% | 0.29% |
| JPMORGAN CHASE & CO | 02/11/2026 | 435.71 K | $1.51 M | 904.19% | 0.27% |
| AQR CAPITAL MANAGEMENT LLC | 02/17/2026 | 415.82 K | $1.44 M | 0.39% | 0.26% |
| HIGHTOWER ADVISORS, LLC | 02/06/2026 | 400.11 K | $1.39 M | 19.88% | 0.25% |
| TWO SIGMA ADVISERS, LP | 02/17/2026 | 383.50 K | $1.33 M | 100.00% | 0.24% |
| BARCLAYS PLC | 02/13/2026 | 363.83 K | $1.26 M | 213.91% | 0.23% |
| BOLLARD GROUP LLC | 02/13/2026 | 361.14 K | $1.25 M | 0.00% | 0.23% |
| WELLS FARGO & COMPANY/MN | 02/13/2026 | 294.50 K | $1.02 M | 49.48% | 0.18% |
| VERITION FUND MANAGEMENT LLC | 02/13/2026 | 290.98 K | $1.01 M | 100.00% | 0.18% |
| NUVEEN, LLC | 02/12/2026 | 251.64 K | $873.18 K | 11.42% | 0.16% |
| WELLINGTON MANAGEMENT GROUP LLP | 02/17/2026 | 248.23 K | $861.35 K | 20.89% | 0.15% |
| PEAK6 LLC | 03/12/2026 | 246.90 K | $856.74 K | -2.57% | 0.15% |
| BANK OF NEW YORK MELLON CORP | 02/10/2026 | 246.77 K | $856.29 K | 24.80% | 0.15% |
| CHELSEA COUNSEL CO | 02/24/2026 | 227.00 K | $787.69 K | 9.02% | 0.14% |
| DARK FOREST CAPITAL MANAGEMENT LP | 02/17/2026 | 225.86 K | $783.73 K | 100.00% | 0.14% |
| SQUAREPOINT OPS LLC | 02/13/2026 | 218.04 K | $756.61 K | 450.60% | 0.14% |
| CITADEL ADVISORS LLC | 02/17/2026 | 204.40 K | $709.27 K | 4.77% | 0.13% |
| GREEN ALPHA ADVISORS, LLC | 01/07/2026 | 190.88 K | $662.36 K | 0.28% | 0.12% |
| CITADEL ADVISORS LLC | 02/17/2026 | 189.10 K | $656.18 K | 44.57% | 0.12% |
| RAFFERTY ASSET MANAGEMENT, LLC | 02/13/2026 | 187.71 K | $651.36 K | 100.00% | 0.12% |
| IQ EQ FUND MANAGEMENT (IRELAND) LTD | 02/12/2026 | 178.52 K | $619.46 K | 47.81% | 0.11% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Prime Medicine Inc institutional Ownership - FAQ's
During the previous two years, 225 institutional investors and hedge funds held shares of Prime Medicine Inc. The most heavily invested institutionals were:
Sumitomo Mitsui Trust Holdings, Inc.: 2.94 M
UBS Group AG: 2.89 M
HighTower Advisors, LLC: 340,255
Nuveen, LLC: 275,931
Bank of New York Mellon Corp: 267,219
CHELSEA COUNSEL CO: 227,000
60.42% of Prime Medicine Inc stock is owned by institutional investors.
Institutional investors have bought a total of 103.68 M shares in the last 24 months. This purchase volume represents approximately $426.11 M in transactions.